USE OF DISABLED IMMUNOSUPPRESSING IMMUNOGEN AND / OR ANGIOGENIC PROTEINS, PREPARATION PROCEDURE AND PHARMACEUTICAL OR VACCINE APPLICATIONS.

摘要

Immunogenic compound, characterized in that it is an initially immunosuppressive and / or angiogenic protein selected from: - the Tat protein of the HIV-1 virus; - the Tax protein of an HTLV-1 virus; and - the E7 protein of papillomavirus; or also a fragment comprising at least 50% of the totality of this protein, and because this protein is deactivated by chemical treatment by carboxamidation or maleimidation.